IAF completes first level of selecting astronauts for Gaganyaan mission from its test pilots pool
New Delhi, Sep 7: The Indian Air Force on Friday said it has completed the first level of selecting astronauts for the ambitious Gaganyaan mission from its pool of test pilots.
The test pilots underwent necessary extensive physical exercise tests, lab investigations, radiological tests, clinical tests and evaluation on various aspects of their psychology, it added.
Air Force sources said 25 test pilots were part of the initial selection process.
This will be a multi-layered selection process and only 2-3 test pilots will make it to the final list, the sources added.
"#MissionGaganyaan -IAF completed Level-1 of Indian Astronaut selection at Institute of Aerospace Medicine. Selected Test Pilots underwent extensive physical exercise tests, lab investigations, radiological tests, clinical tests & evaluation on various facets of their psychology," the IAF tweeted.
The first Gaganyaan flight scheduled for 2022 will carry three astronauts, who will be picked from among the test pilots in the armed forces.
"Most maiden missions undertaken by different countries in the past had test pilots. So we are sticking to that for our maiden mission. We are also looking at test pilots from the armed forces which don't have woman as test pilots," an ISRO official said.
The short-listed candidate is being done in batches and the candidates will be sent to Russia for training after November.
India's first man in space Rakesh Sharma, who flew aboard the Soyuz T-11, launched on April 2, 1984, was an Indian Air Force pilot.
The ambitious Gaganyaan mission was announced by Prime Minister Narendra Modi during his Independence Day speech in 2018.
Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.
Ballari maternal deaths: Karnataka govt. seeks explanation from CDSCO
Bengaluru: The Karnataka Government has sought clarification from the Central drugs standard control organisation following reports linking the serial deaths of pregnant women at Ballari District Hospital to unsafe IV Ringer's Lactate solution. Health Department Principal Secretary Harsha Gupta has written a letter to the Drugs Controller General of India, Rajeev Singh Raghuvanshi.
Recent Investigations revealed bacterial and fungal contaminants in the IV solution given to the women. Out of 192 batches supplied by a West Bengal-based pharmaceutical company, 22 were found substandard by the state drug control department, leading to the suspension of the medicine's use.
However, these batches had passed quality tests at the Central Drug Lab, creating a regulatory conflict.
The Health Department emphasized adherence to tender rules, stating that the Central Drug Lab's approval is legally binding. Samples from the problematic batches have been sent for re-testing at the central lab in West Bengal, with results expected on December 9.
As a precautionary measure, the state has blacklisted the implicated batches and issued directives to halt their use in all hospitals.
